Literature DB >> 17885701

Hyperemesis gravidarum--assessment and management.

Penny Sheehan1.   

Abstract

BACKGROUND: Nausea and vomiting are common symptoms in early pregnancy. In most women the condition is mild and self limiting. A small percentage of women experience severe nausea and vomiting. This is known as hyperemesis gravidarum. Outcomes have improved with intravenous rehydration therapy. Consequences include decreased quality of life, time off work and secondary depression.
OBJECTIVE: This article outlines the aetiology, outcomes, history and examination of women with hyperemesis gravidarum. Treatment modalities are discussed together with evidence regarding use. DISCUSSION: It is important to exclude other causes of nausea and vomiting such as urinary tract infection and thyrotoxicosis. Assessment of severity by checking for ketones is important as severity determines management. Management will include rehydration (intravenous or oral). Evidence is lacking regarding dietary and lifestyle recommendations but some women find them useful. Pyridoxine and metoclopramide (category A) are first line in treatment of hyperemesis gravidarum followed by prochlorperazine (category C), prednisolone (category A), promethazine (category C) and ondansetron (category B1). Benefit has been reported with the use of ginger. Evidence is mixed regarding acupressure and acupuncture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885701

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  10 in total

1.  In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner.

Authors:  Ramadhan Oruch; Erlend Hodneland; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2009-04-30

Review 2.  Treatment options for hyperemesis gravidarum.

Authors:  Amy Abramowitz; Emily S Miller; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2017-01-09       Impact factor: 3.633

3.  Motherisk and Canadian Family Physician.

Authors:  Nicholas Pimlott; Brent Kvern; Robert Woollard
Journal:  Can Fam Physician       Date:  2017-01       Impact factor: 3.275

4. 

Authors:  Nicholas Pimlott; Brent Kvern; Robert Woollard
Journal:  Can Fam Physician       Date:  2017-01       Impact factor: 3.275

Review 5.  Challenges in interventional radiology: the pregnant patient.

Authors:  Eunice K Moon; Weiping Wang; James S Newman; Maria Del Pilar Bayona-Molano
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

Review 6.  Gut microbiota in gastrointestinal diseases during pregnancy.

Authors:  Zhong-Zhen Liu; Jing-Hua Sun; Wen-Jing Wang
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

7.  Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum.

Authors:  Enis Ozkaya; Evrim Cakır; Mehmet Cınar; Metin Altay; Orhan Gelişen; Fadıl Kara
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

Review 8.  Managing hyperemesis gravidarum: a multimodal challenge.

Authors:  J K Jueckstock; R Kaestner; I Mylonas
Journal:  BMC Med       Date:  2010-07-15       Impact factor: 8.775

9.  [Hyperemesis gravidarum with severe electrolyte disorders: report of a case].

Authors:  Anouar Jarraya; Sahar Elleuch; Jawhar Zouari; Khaled Trigui; Abidi Sofiene; Mohamed Smaoui; Kamel Kolsi
Journal:  Pan Afr Med J       Date:  2015-03-19

10.  The association between maternal smoking during pregnancy and childhood obesity persists to the age of 9-10 years.

Authors:  Kohta Suzuki; Daisuke Ando; Miri Sato; Taichiro Tanaka; Naoki Kondo; Zentaro Yamagata
Journal:  J Epidemiol       Date:  2009-04-28       Impact factor: 3.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.